BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee CG, Lim YJ, Park SJ, Jang BI, Choi SR, Kim JK, Kim YT, Cho JY, Yang CH, Chun HJ, Song SY; Neuroendocrine tumor study group. The clinical features and treatment modality of esophageal neuroendocrine tumors: a multicenter study in Korea. BMC Cancer. 2014;14:569. [PMID: 25098730 DOI: 10.1186/1471-2407-14-569] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang G, Wu B, Wang X, Li J. A competing-risks nomogram and recursive partitioning analysis for cause-specific mortality in patients with esophageal neuroendocrine carcinoma. Dis Esophagus. 2019;32:doy129. [PMID: 30715226 DOI: 10.1093/dote/doy129] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
2 Babu Kanakasetty G, Dasappa L, Lakshmaiah KC, Kamath M, Jacob LA, Mallekavu SB, Rajeev LK, Haleshappa RA, Kadabur Nagendrappa L, Saldanha SC, Kumar RV. Clinicopathological Profile of Pure Neuroendocrine Neoplasms of the Esophagus: A South Indian Center Experience. J Oncol. 2016;2016:2402417. [PMID: 27340404 DOI: 10.1155/2016/2402417] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
3 Xu Y, Li X, Xu YF, Yang XM. Poorly Differentiated Esophageal Neuroendocrine Carcinoma Treated With the CDK4/6 Inhibitor, Palbociclib: A Case Report and Literature Review. Am J Ther 2018;25:e595-8. [PMID: 29232286 DOI: 10.1097/MJT.0000000000000610] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
4 Watson GA, Ahmed Y, Picardo S, Chew S, Cobbe S, Mahony C, Crotty J, Wallis F, Shelly MJ, Kiely P, Ipadeola OB, Healy V, Osman N, Gupta RK. Unusual Sites of High-Grade Neuroendocrine Carcinomas: A Case Series and Review of the Literature. Am J Case Rep. 2018;19:710-723. [PMID: 29915166 DOI: 10.12659/ajcr.908953] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Hu Q, Jin P, Zhao X, Wu W, Huang B, Shao S, Que R, Liang T. Esophageal neuroendocrine carcinoma complicated with unexpected hyperprocalcitonin: Case report and literature review. Medicine (Baltimore) 2018;97:e12219. [PMID: 30290592 DOI: 10.1097/MD.0000000000012219] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
6 Kim MH, Jeong HY, Seong JK, Moon HS, Kang SH, Kim DK. A Case of Endoscopically Complete Remission of Esophageal Neuroendocrine Tumors by Concurrent Chemoradiation Therapy. Korean J Gastroenterol 2016;68:265. [DOI: 10.4166/kjg.2016.68.5.265] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
7 Schizas D, Mastoraki A, Kirkilesis GI, Sioulas AD, Papanikolaou IS, Misiakos EP, Arkadopoulos N, Liakakos T. Neuroendocrine Tumors of the Esophagus: State of the Art in Diagnostic and Therapeutic Management. J Gastrointest Cancer. 2017;48:299-304. [PMID: 28656561 DOI: 10.1007/s12029-017-9978-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
8 Liu S, Ge X, Gao Z, Zhou Q, Shi Y, Jiang W, Yang M, Sun X. Clinicopathological analysis of 67 cases of esophageal neuroendocrine carcinoma and the effect of postoperative adjuvant therapy on prognosis. Medicine (Baltimore) 2021;100:e27302. [PMID: 34713821 DOI: 10.1097/MD.0000000000027302] [Reference Citation Analysis]
9 Branstetter H, Agarwal A, Paulson S, Nguyen AD, Konda V. Early esophageal neuroendocrine tumor. Proc (Bayl Univ Med Cent) 2022;35:80-1. [PMID: 34970043 DOI: 10.1080/08998280.2021.1955562] [Reference Citation Analysis]
10 Kong ZZ, Zhang L. Esophagogastric junctional neuroendocrine tumor with adenocarcinoma: A case report. World J Clin Cases 2022; 10(18): 6241-6246 [DOI: 10.12998/wjcc.v10.i18.6241] [Reference Citation Analysis]
11 Wang H, Chen Y, Pi G, Zhu Y, Yang S, Mei H, Lin Z, Zhang T. Validation and proposed modification of the 8th edition American Joint Committee on Cancer staging system for patients with esophageal neuroendocrine neoplasms: Evaluation of a revised lymph node classification. Oncol Lett. 2020;19:4122-4132. [PMID: 32382351 DOI: 10.3892/ol.2020.11480] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Erdem S, Troxler E, Warschkow R, Tsai C, Yerokun B, Schmied B, Stettler C, Blazer DG 3rd, Hartwig M, Worni M, Gloor B. Is There a Role for Surgery in Patients with Neuroendocrine Tumors of the Esophagus?Ann Surg Oncol. 2020;27:671-680. [PMID: 31605338 DOI: 10.1245/s10434-019-07847-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
13 Kuriry H, Swied AM. Large-Cell Neuroendocrine Carcinoma of the Esophagus: A Case from Saudi Arabia. Case Rep Gastroenterol. 2015;9:327-334. [PMID: 26600769 DOI: 10.1159/000441381] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wang MM, Singh SK. Rapidly Extensive Recurrence of Esophageal Neuroendocrine Carcinoma After Complete Pathologic Response to Definitive Chemoradiation. ACG Case Rep J 2022;9:e00730. [DOI: 10.14309/crj.0000000000000730] [Reference Citation Analysis]
15 Khonglah Y, Jitani AK, Gogoi BB, Hage N, Devi LP, Lynrah KG. Concurrent Lesions in Oesophagus: an Approach to Diagnosis with a Case Report. J Gastrointest Cancer 2017;48:201-4. [PMID: 27105636 DOI: 10.1007/s12029-016-9822-8] [Reference Citation Analysis]
16 Borbath I, Pape UF, Deprez PH, Bartsch DK, Caplin M, Falconi M, Garcia-Carbonero R, Grozinsky-Glasberg S, Jensen RT, Arnold R, Ruszniewski P, Toumpanakis C, Valle JW, O Toole D; Members of the Advisory Board of the European Neuroendocrine Tumor Society (ENETS). ENETS standardized (synoptic) reporting for endoscopy in neuroendocrine tumors. J Neuroendocrinol 2022;:e13105. [PMID: 35233848 DOI: 10.1111/jne.13105] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
17 Giannetta E, Guarnotta V, Rota F, de Cicco F, Grillo F, Colao A, Faggiano A; NIKE. A rare rarity: Neuroendocrine tumor of the esophagus. Crit Rev Oncol Hematol 2019;137:92-107. [PMID: 31014519 DOI: 10.1016/j.critrevonc.2019.02.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
18 Fujihara S, Kobayashi M, Nishi M, Yachida T, Yoshitake A, Deguchi A, Muraoka A, Kobara H, Masaki T. Composite neuroendocrine carcinoma and squamous cell carcinoma with regional lymph node metastasis: a case report. J Med Case Rep. 2018;12:227. [PMID: 30139375 DOI: 10.1186/s13256-018-1775-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
19 Deng HY, Ni PZ, Wang YC, Wang WP, Chen LQ. Neuroendocrine carcinoma of the esophagus: clinical characteristics and prognostic evaluation of 49 cases with surgical resection. J Thorac Dis. 2016;8:1250-1256. [PMID: 27293844 DOI: 10.21037/jtd.2016.04.21] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 5.5] [Reference Citation Analysis]
20 Wu IC, Chu YY, Wang YK, Tsai CL, Lin JC, Kuo CH, Shih HY, Chung CS, Hu ML, Sun WC, Wang JP, Wang HP. Clinicopathological features and outcome of esophageal neuroendocrine tumor: A retrospective multicenter survey by the digestive endoscopy society of Taiwan. J Formos Med Assoc 2021;120:508-14. [PMID: 32600867 DOI: 10.1016/j.jfma.2020.06.024] [Reference Citation Analysis]
21 Ye L, Lu H, Wu L, Zhang L, Shi H, Wu HM, Tu P, Li M, Wang FY. The clinicopathologic features and prognosis of esophageal neuroendocrine carcinomas: a single-center study of 53 resection cases. BMC Cancer. 2019;19:1234. [PMID: 31852479 DOI: 10.1186/s12885-019-6420-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
22 Ma Z, Cai H, Cui Y. Progress in the treatment of esophageal neuroendocrine carcinoma. Tumour Biol. 2017;39:1010428317711313. [PMID: 28653897 DOI: 10.1177/1010428317711313] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
23 Sanghi V, Amin H, Sanaka MR, Thota PN. Resection of early esophageal neoplasms: The pendulum swings from surgical to endoscopic management. World J Gastrointest Endosc 2019; 11(10): 491-503 [PMID: 31798770 DOI: 10.4253/wjge.v11.i10.491] [Reference Citation Analysis]
24 Tao H, Li F, Wang J, Dong W, Gao J, Jiao S, Hu Y. Management of treatment-naïve limited-stage small cell esophagus carcinoma. Saudi Med J 2015;36:297-303. [PMID: 25737171 DOI: 10.15537/smj.2015.3.11368] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
25 Chen C, Hu H, Zheng Z, Yang Y, Chen W, Qiao X, Li P, Zhang S. Clinical characteristics, prognostic factors, and survival trends in esophageal neuroendocrine carcinomas: A population-based study. Cancer Med 2022. [PMID: 35596661 DOI: 10.1002/cam4.4829] [Reference Citation Analysis]
26 Tustumi F, Takeda FR, Uema RH, Pereira GL, Sallum RA, Cecconello I. Primary neuroendocrine neoplasm of the esophagus - Report of 14 cases from a single institute and review of the literature. Arq Gastroenterol. 2017;54:4-10. [PMID: 28079231 DOI: 10.1590/s0004-2803.2017v54n1-01] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
27 Li Z, Hu J, Chen P, Zeng Z. Incidence, treatment, and survival analysis in esophageal neuroendocrine carcinoma population. Transl Cancer Res 2020;9:4317-29. [PMID: 35117798 DOI: 10.21037/tcr-19-2650] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Savva C, Kaye P, Soomro I, Parsons SL, James E, Madhusudan S. Primary Esophagogastric Neuroendocrine Carcinoma: a Retrospective Study from the Nottingham Upper Gastrointestinal Cancer Center. J Gastrointest Cancer 2018;49:85-92. [PMID: 29230683 DOI: 10.1007/s12029-017-0039-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
29 Chin YP, Lai WF, Chiang MT, Chang SC. Esophageal neuroendocrine tumor with initial presentation as painless forehead and neck masses: A case report. Medicine (Baltimore) 2017;96:e9282. [PMID: 29390385 DOI: 10.1097/MD.0000000000009282] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Saddoughi SA, Taswell J, Harmsen WS, Inra ML, Blackmon SH, Nichols FC 3rd, Cassivi SD, Wigle DA, Shen KR, Allen MS. Surgical Resection of Rare Esophageal Cancers. Ann Thorac Surg 2016;101:311-5. [PMID: 26277558 DOI: 10.1016/j.athoracsur.2015.06.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
31 Chin JL, O'Toole D. Diagnosis and Management of Upper Gastrointestinal Neuroendocrine Tumors. Clin Endosc. 2017;50:520-529. [PMID: 29207862 DOI: 10.5946/ce.2017.181] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]